At Home with Hostility

By Thomas Ruby and Denise M. Monack At Home with Hostility How do pathogenic bacteria evade mammalian immune surveillance to establish persistent infection? Tuberculosis infection Scott Camazine / Photo Researchers, Inc. Long-term bacterial infections pose several fundamental biological questions: How metabolically active are bacteria during a persistent infection? Are they dividing, or in a state of quiescence? And how do these bacteria evade the immune system

Written byThomas Ruby and Denise M. Monack
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Long-term bacterial infections pose several fundamental biological questions: How metabolically active are bacteria during a persistent infection? Are they dividing, or in a state of quiescence? And how do these bacteria evade the immune system for so long?

Acute infections by pathogenic bacteria cause a dramatic activation of the innate and adaptive immune responses. If the pathogen survives initial contact with the host’s innate immune system (and the host is not killed), the infection is usually cleared by the host’s adaptive immune system. However, some bacterial pathogens maintain infections for the lifetime of their mammalian hosts, even in the presence of a robust immune response.

Most of what we’ve learned about persistent infections comes from the study of several well-known illnesses. For example, Helicobacter pylori, the cause of most stomach ulcers, inhabits the stomach lining, where its persistence can be lifelong; Mycobacterium tuberculosis is able to establish long-term infections that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform